Reducing pulse pressures and vascular stiffness in hypertensive patients by administering a vasopeptidase inhibitor
OwnerAlan J. Blockinventor
Life of this patent
Estimating the term…
Abstract
Vasopeptidase inhibitors, especially omapatrilat, are useful in reducing central and peripheral pulse pressure and vascular stiffness in hypertensive patients. The vasopeptidase inhibitor may be used in combination with other pharmaceutically active agents.
Claims13
A method of reducing central and peripheral pulse pressure and vascular stiffness in a hypertensive patient comprising administering an effective amount of vasopeptidase inhibitor.
The method of reducing central and peripheral pulse pressure and vascular stiffness in a hypertensive patient comprising administering an effective amount of a vasopeptidase inhibitor and another pharmaceutically active agent.
Dependencies are inferred from the claim text.